Natera Product Brochure

HIPAA Authorization to Release Records to a Partner/Significant-other

Analytical validation of the Altera tumor genomic profiling test

Signatera and Altera Insurance Coverage and Billing

The first personalized ctDNA test to identify molecular residual disease and optimize treatment decisions. Read our billing guide for information about understanding Natera's genetic testing bill.

Tumor Genomic Profile

Altera offers a whole exome and transcriptome-based approach for Comprehensive Genomic Profiling (CGP) with boosted >500X coverage for 440 medically important genes.

Signatera Altera Empower Requisition Form

Form necessary to request Signatera tests for use with patients.